NCT02197377

Brief Summary

With an aging population a prevalence of edentulous patients increased above 60 % among individuals aged ≥65 yr. Face mask ventilation of these edentulous patients is often difficult because of the inadequate fitting of the standard mask to the face. In addition, because of a reduction in muscle tone under general anesthesia, the air space in the oropharynx is reduced, and posterior displacement of the tongue, soft palate and epiglottis tend to close the airway. The laryngeal mask airway (LMA) provides a better alternative to the standard face mask if the facial contours of the patient are not suited to the standard face mask. It is more difficult to perform bag-mask ventilation in edentulous patients than in patients with intact dentition. The laryngeal mask airway (LMA) provides a better alternative to the standard face mask if the facial contours of the patient are not suited to the standard face mask. We aimed to compare the routinely used laryngeal mask airway in our clinic, the LMA Unique™ with the newly released LMA Supreme™ in edentulous elderly patients for the success in first attempt insertion, ease and time of insertion, and oropharyngeal leak pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
4.2 years until next milestone

First Submitted

Initial submission to the registry

July 21, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 22, 2014

Completed
4.2 years until next milestone

Results Posted

Study results publicly available

October 19, 2018

Completed
Last Updated

October 19, 2018

Status Verified

December 1, 2017

Enrollment Period

8 months

First QC Date

July 21, 2014

Results QC Date

April 26, 2015

Last Update Submit

December 20, 2017

Conditions

Keywords

Laryngeal mask airway, edentulous geriatric patient

Outcome Measures

Primary Outcomes (1)

  • First Attempt's Success Rate of Insertion

    Edentulous elderly patients for the success in first attempt insertion, ease and time of insertion (second).

    after anaesthesia induction

Secondary Outcomes (1)

  • Oropharyngeal Leak Pressure

    before surgery

Study Arms (2)

Group LMA Unique

ACTIVE COMPARATOR

The supraglottic airway devices were deflated fully before insertion. Size 4 LMA was used for those with a weight of 50-70 kg and size 5 LMA for those between 70-100 kg. After insertion, each device was inflated with a hand-held airway manometer (Rusch, Germany) to an intracuff pressure of 60 cm H2O.The oropharyngeal leak pressure was determined by transiently stopping ventilation and closing the adjustable pressure-limiting valve with a fresh gas flow of 3 L/min until airway pressure reached a steady state and a voice of leakage was heard. The airway pressure was not allowed to exceed 40 cm H2O.

Device: Group LMA Unique™

Group LMA Supreme

EXPERIMENTAL

The supraglottic airway devices were deflated fully before insertion. Size 4 LMA was used for those with a weight of 50-70 kg and size 5 LMA for those between 70-100 kg. After insertion, each device was inflated with a hand-held airway manometer (Rusch, Germany) to an intracuff pressure of 60 cm H2O.The oropharyngeal leak pressure was determined by transiently stopping ventilation and closing the adjustable pressure-limiting valve with a fresh gas flow of 3 L/min until airway pressure reached a steady state and a voice of leakage was heard. The airway pressure was not allowed to exceed 40 cm H2O.

Device: Group LMA Supreme™

Interventions

The supraglottic airway devices were deflated fully before insertion. After placement an effective airway was defined as the presence of normal thoracoabdominal movement and a square-wave end-tidal carbon dioxide trace.

Also known as: Laryngeal Mask Airway Unique, LMA Unique (The Laryngeal Mask Company Limited, Singapore)
Group LMA Unique

The supraglottic airway devices were deflated fully before insertion.The supraglottic airway devices were deflated fully before insertion. After placement an effective airway was defined as the presence of normal thoracoabdominal movement and a square-wave end-tidal carbon dioxide trace.

Also known as: Laryngeal Mask Airway Supreme, Teleflex, The Laryngeal Mask Company Limited, Singapore
Group LMA Supreme

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • ASA I-III
  • years and older

You may not qualify if:

  • Any neck or upper respiratory pathology
  • Those at risk of gastric content regurgitation/aspiration (previous upper gastro-intestina system surgery, known hiatus hernia, gastroesophageal reflux, history of peptic ulcer, full stomach, pregnancy)
  • Possibility of and those with history of difficult intubation (history of impossible intubation, Mallampati classification 3-4, sterno mental distance less than 12 cm, thyromental distance less than 6 cm, head extension less than 90 degrees, mouth opening less than 1.5 cm)
  • Those with low pulmonary compliance or high airway resistance (morbid obesity, lung disease)
  • Throat pain, dysphagia and dysphonia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation

Izmi̇r, Narlıdere, 35320, Turkey (Türkiye)

Location

Results Point of Contact

Title
Anaesthesiology and Reanimation
Organization
DorkuzEU

Study Officials

  • TANGUL KILIÇ, M.D.

    Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation

    PRINCIPAL INVESTIGATOR
  • SEMİH KUCUKGUCLU, M.D.

    Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anaesthesiology and Reanimation

Study Record Dates

First Submitted

July 21, 2014

First Posted

July 22, 2014

Study Start

August 1, 2009

Primary Completion

April 1, 2010

Study Completion

May 1, 2010

Last Updated

October 19, 2018

Results First Posted

October 19, 2018

Record last verified: 2017-12

Locations